Evidence map›Paper›PMID 25093882›Full record

ArticleNature biotechnology2014

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.

Peter W Andrews, Joy Cavagnaro, Joy Cavanagro, Robert Deans, Ellen Feigal, Ellen Feigel, Ed Horowitz, Armand Keating, Mahendra Rao, Marc Turner and 2 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Establishment of a keratinocyte and fibroblast bank for clinical applications in Japan.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
    Cavanagro, Joy [corrected to Cavagnaro, Joy]; Feigel, Ellen [corrected to Feigal, Ellen]
5 · Who and what money

Authors and funding

12 authors.

Peter W Andrews1] Centre for Stem Cell Biology, Department of Biomedical Science, University of Sheffield Western Bank, Sheffield, UK. [2] Coordinator of the International Stem Cell Initiative.
Joy Cavagnaro
Joy CavanagroAccess BIO, Boyce, Virginia, USA.
Robert DeansAlliance for Regenerative Medicine/Athersys, Cleveland, Ohio, USA.
Ellen Feigal
Ellen FeigelCalifornia Institute for Regenerative Medicine, San Francisco, California, USA.
Ed HorowitzInternational Society for Cell Therapy, Vancouver, BC, Canada.
Armand KeatingAmerican Society of Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada.
Mahendra Rao1] National Institutes of Health Center for Regenerative Medicine, Bethesda, Maryland, USA. [2] New York Stem Cell Foundation, New York, New York, USA.
Marc TurnerScottish National Blood Transfusion Service Headquarters, Edinburgh, UK.
Ian WilmutScottish Center for Regenerative Medicine, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.
Shinya Yamanaka1] Kyoto Center for iPS Cell Research and Application, Kyoto University, Shogoin, Sakyo-ku, Kyoto, Japan. [2] International Society for Stem Cell Research at the time of submission and acceptance of this work.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiotechnologyCell- and Tissue-Based TherapyHumansPluripotent Stem Cells

Identifiers

PMID25093882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.